MELISSA VELEZ: Open Payments
NPI 1639392855 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,587 in 147 payments from 30 companies in 2025. Trend: 2023 $8,116 · 2024 $25,636 · 2025 $14,587
Speaker / faculty: $9,622Food & beverage: $4,297Travel & lodging: $345Education: $174Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 25 | $11,174 |
| Biogen, Inc. | 28 | $998 |
| TG Therapeutics, Inc. | 10 | $507 |
| Abbott Laboratories | 5 | $281 |
| Alnylam Pharmaceuticals Inc. | 10 | $190 |
| MDD US Operations, LLC | 15 | $162 |
| Teva Pharmaceuticals USA, Inc. | 5 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Alexion Pharmaceuticals, Inc. | 4 | $101 |
Products named: Mavenclad, BRIUMVI, TYSABRI, VUMERITY, INFINITY, AMVUTTRA, Leqembi, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
